Aprotinin

Trasylol

2,000,000KIU/200ML InjectionUnited StatesWithdrawnAuthorised 29 Dec 1993

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

TrasylolBrazil · Bayer S.A.Same brand
TrasylolBrazil · Bayer S.A.Same brand
TrasylolCanada · 10000 UNIT / ML · Solution · Nordic Group B.V.Same brand
Trasylol Inj 10000 Kiu/MLCanada · 100000 UNIT / AMP · Liquid · Miles Canada INC. - Pharmaceutical DivisionSame brand
Trasylol, oplossing voor infusie 10.000 KIE/mlNetherlands · Oplossing voor infusie · Nordic Group B.V.Same brand
TRASYLOL INJECTION 500,000 kiu/50 mlSingapore · 500000 kiu/50 ml · injection · Link Healthcare Singapore Pte LTD

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Aprotinin

Trasylol

2,000,000KIU/200ML InjectionUnited StatesWithdrawnAuthorised 29 Dec 1993

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Trasylol Injection 10,000 Kiu/MLTaiwan · 注射劑 · 臺灣拜耳股份有限公司

AnyNew Zealand · Inj 10,000 kIU per ml (equivalent to 200 mg per ml), 50 ml vial

Documents

The official texts, at the regulator.

Register entryFDA

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Aprotinin
Strength: 2,000,000KIU/200ML
Dosage form: Injection
Route: Intravenous
Register: United States (FDA)
Status: Withdrawn
Status in the register: Voluntarily Revoked / Disc
Authorised: 29 Dec 1993
Registration: BLA 020304
Marketing authorisation holder: Bayer HealthCare Pharmaceuticals Inc.
Procedure: 351(a)
Supply: Disc